Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFu Jen Catholic University
About this trial
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Eligibility criteria
Qualifiers
Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
Signed informed consent.
Disqualifiers
Patients under the age of 18.
Patients with malignancies other than lung adenocarcinoma.
Trial design
Treatments tested in this trial
- biomarkers
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov